Aptamer Group PLC (AIM:APTA)

Market Cap	24.27M
Revenue (ttm)	1.20M
Net Income (ttm)	-2.42M
Shares Out	2.70B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,300,648
Average Volume	5,137,510
Open	0.9500
Previous Close	0.9000
Day's Range	0.8500 - 0.9500
52-Week Range	0.2311 - 1.5700
Beta	0.78
RSI	43.50
Earnings Date	Mar 11, 2026

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and b...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 31
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In 2025, Aptamer Group's revenue was 1.20 million, an increase of 39.88% compared to the previous year's 860,000. Losses were -2.42 million, -18.05% less than in 2024.